⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMGN News
Amgen Inc
Generalized Myasthenia Gravis Market on the Brink of Change: 8 Promising Late-Stage Drugs Signal a New Treatment Era | DelveInsight
globenewswire.com
IMVT
ROIV
CART
NVS
MRK
REGN
UCB
JNJ
AMGN
ARGX
KYMR
CABA
BMY
BHVN
Sport Beach is Back for Cannes 2026
accessnewswire.com
ADBE
PEP
EA
TTD
Z
TROW
AMZN
DDOG
F
GOOG
INTC
META
NFLX
NVDA
SPOT
STX
TSLA
CRM
SPGI
MSFT
GOOGL
FDX
CMCSA
DIS
AAPL
IBM
GE
BA
GS
JPM
BAC
WMT
COST
TGT
BABA
JD
PDD
ETSY
EBAY
PYPL
COIN
HOOD
UPST
SOFI
PLTR
SNOW
CRWD
PANW
ZS
FTNT
DD
DOW
LMT
GD
RTX
CAT
DE
AGCO
CNH
HON
MMM
XOM
CVX
SHEL
T
VZ
TMUS
LYFT
UBER
GILD
AMGN
BMY
PFE
MRK
JNJ
ABBV
LLY
NVS
AZN
BIIB
REGN
VRTX
MDLZ
KHC
CL
PG
BANC
The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight
globenewswire.com
JNJ
PFE
ABBV
LLY
AMGN
INCY
GILD
BHC
AZN
SUN
Uplizna Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts 2020-2035
globenewswire.com
AMGN
Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight
globenewswire.com
AMGN
AZN
DBVT
GSK
B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Report 2026 - Worth $18.75 Billion in 2026, the Market is Expected to Reach $44.29 Billion by 2030
globenewswire.com
JNJ
AZN
BMY
NVS
GSK
AMGN
Francois Schramek Promoted to Partner at Manhattan West
prnewswire.com
AI
AMN
GM
LMT
NVDA
GOOG
MSFT
SPCE
RKLB
GD
BA
AMD
INTC
META
CRWD
PLTR
AN
DD
HON
RTX
IBM
AMZN
TSLA
XOM
CVX
UNH
BMY
PFE
MRK
JNJ
LLY
GILD
REGN
BIIB
AMGN
AZN
NVO
SNY
TEVA
BABA
JD
NTES
BIDU
IQ
VIPS
BZUN
HTHT
MELI
BBD
BB
ERIC
NOK
QCOM
MU
ADSK
CRM
GOOGL
Bispecific Antibodies Market Research and Competitive Landscape Report 2026: Comprehensive Insights Into Over 180 Companies and 250 Drugs
globenewswire.com
JNJ
AMGN
AZN
MAC
Advocacy Marketing Partners Adds Executive Leader
accessnewswire.com
AMGN
JNJ
HPQ
AAPL
LLY
Acute Respiratory Distress Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 40+ Key Companies | DelveInsight
globenewswire.com
EDSA
VERU
PLTR
HLIO
DRCT
BHVN
CART
AMGN
AROW
AZN
GSK
NVS
SNDX
SNY
UNH
VRTX